Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms

Shugang Xi, Guihua Zhou, Xuexin Zhang, Wenjie Zhang, Lu Cai, Chunyan Zhao

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Total aralosides of Aralia elata (Miq) Seem (TASAES) from Chinese traditional herb Longya Aralia chinensis L was found to improve cardiac function. The present study was to determine the protective effects of TASAES on diabetic cardiomyopathy, and the possible mechanisms. Therefore, a single dose of streptozotocin was used to induce diabetes in Wister rats. Diabetic rats were immediately treated with low, medium and high doses of TASAES at 4.9, 9.8 mg/kg and 19.6 mg/kg body weight by gavage, respectively, for eight weeks. Cardiac function was evaluated by in situ hemodynamic measurements, and patch clamp for the L-type Ca 2+ channel current (I Ca2+-L ) and transient outward K + channel current (I to ). Histopathological changes were observed under light and electron microscope. The expression of pro-fibrotic factor, connective tissue growth factor (CTGF) was monitored using immunohistochemistry staining. Compared with diabetic group, medium and high doses, but not low dose, of TASAES showed a significant protection against diabetes-induced cardiac dysfunction, shown by increased absolute value of left ventricular systolic pressure (LVSP) and maximum rates of pressure development (±dp/dt max ), and enhanced amplitude of I Ca2+-L (P < 0.05). Histological staining indicated a significant inhibition of diabetes-caused pathological changes and up-regulation of CTGF expression (P < 0.05). The results suggest that TASAES prevents diabetes-induced cardiac dysfunction and pathological damage through up-regulating I Ca2+-L in cardiac cells and decreasing CTGF expression.

Original languageEnglish (US)
Pages (from-to)538-547
Number of pages10
JournalExperimental and Molecular Medicine
Volume41
Issue number8
DOIs
StatePublished - Aug 31 2009

Fingerprint

Aralia
Diabetic Cardiomyopathies
Medical problems
Connective Tissue Growth Factor
Rats
Clamping devices
Hemodynamics
Streptozocin
Staining and Labeling
Electron microscopes
Ventricular Pressure
Up-Regulation
Immunohistochemistry
Body Weight
Electrons
Blood Pressure
Light
Pressure

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

@article{9863af20beee4e37b8d9b4cd13d67301,
title = "Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms",
abstract = "Total aralosides of Aralia elata (Miq) Seem (TASAES) from Chinese traditional herb Longya Aralia chinensis L was found to improve cardiac function. The present study was to determine the protective effects of TASAES on diabetic cardiomyopathy, and the possible mechanisms. Therefore, a single dose of streptozotocin was used to induce diabetes in Wister rats. Diabetic rats were immediately treated with low, medium and high doses of TASAES at 4.9, 9.8 mg/kg and 19.6 mg/kg body weight by gavage, respectively, for eight weeks. Cardiac function was evaluated by in situ hemodynamic measurements, and patch clamp for the L-type Ca 2+ channel current (I Ca2+-L ) and transient outward K + channel current (I to ). Histopathological changes were observed under light and electron microscope. The expression of pro-fibrotic factor, connective tissue growth factor (CTGF) was monitored using immunohistochemistry staining. Compared with diabetic group, medium and high doses, but not low dose, of TASAES showed a significant protection against diabetes-induced cardiac dysfunction, shown by increased absolute value of left ventricular systolic pressure (LVSP) and maximum rates of pressure development (±dp/dt max ), and enhanced amplitude of I Ca2+-L (P < 0.05). Histological staining indicated a significant inhibition of diabetes-caused pathological changes and up-regulation of CTGF expression (P < 0.05). The results suggest that TASAES prevents diabetes-induced cardiac dysfunction and pathological damage through up-regulating I Ca2+-L in cardiac cells and decreasing CTGF expression.",
author = "Shugang Xi and Guihua Zhou and Xuexin Zhang and Wenjie Zhang and Lu Cai and Chunyan Zhao",
year = "2009",
month = "8",
day = "31",
doi = "10.3858/emm.2009.41.8.059",
language = "English (US)",
volume = "41",
pages = "538--547",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "8",

}

Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms. / Xi, Shugang; Zhou, Guihua; Zhang, Xuexin; Zhang, Wenjie; Cai, Lu; Zhao, Chunyan.

In: Experimental and Molecular Medicine, Vol. 41, No. 8, 31.08.2009, p. 538-547.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms

AU - Xi, Shugang

AU - Zhou, Guihua

AU - Zhang, Xuexin

AU - Zhang, Wenjie

AU - Cai, Lu

AU - Zhao, Chunyan

PY - 2009/8/31

Y1 - 2009/8/31

N2 - Total aralosides of Aralia elata (Miq) Seem (TASAES) from Chinese traditional herb Longya Aralia chinensis L was found to improve cardiac function. The present study was to determine the protective effects of TASAES on diabetic cardiomyopathy, and the possible mechanisms. Therefore, a single dose of streptozotocin was used to induce diabetes in Wister rats. Diabetic rats were immediately treated with low, medium and high doses of TASAES at 4.9, 9.8 mg/kg and 19.6 mg/kg body weight by gavage, respectively, for eight weeks. Cardiac function was evaluated by in situ hemodynamic measurements, and patch clamp for the L-type Ca 2+ channel current (I Ca2+-L ) and transient outward K + channel current (I to ). Histopathological changes were observed under light and electron microscope. The expression of pro-fibrotic factor, connective tissue growth factor (CTGF) was monitored using immunohistochemistry staining. Compared with diabetic group, medium and high doses, but not low dose, of TASAES showed a significant protection against diabetes-induced cardiac dysfunction, shown by increased absolute value of left ventricular systolic pressure (LVSP) and maximum rates of pressure development (±dp/dt max ), and enhanced amplitude of I Ca2+-L (P < 0.05). Histological staining indicated a significant inhibition of diabetes-caused pathological changes and up-regulation of CTGF expression (P < 0.05). The results suggest that TASAES prevents diabetes-induced cardiac dysfunction and pathological damage through up-regulating I Ca2+-L in cardiac cells and decreasing CTGF expression.

AB - Total aralosides of Aralia elata (Miq) Seem (TASAES) from Chinese traditional herb Longya Aralia chinensis L was found to improve cardiac function. The present study was to determine the protective effects of TASAES on diabetic cardiomyopathy, and the possible mechanisms. Therefore, a single dose of streptozotocin was used to induce diabetes in Wister rats. Diabetic rats were immediately treated with low, medium and high doses of TASAES at 4.9, 9.8 mg/kg and 19.6 mg/kg body weight by gavage, respectively, for eight weeks. Cardiac function was evaluated by in situ hemodynamic measurements, and patch clamp for the L-type Ca 2+ channel current (I Ca2+-L ) and transient outward K + channel current (I to ). Histopathological changes were observed under light and electron microscope. The expression of pro-fibrotic factor, connective tissue growth factor (CTGF) was monitored using immunohistochemistry staining. Compared with diabetic group, medium and high doses, but not low dose, of TASAES showed a significant protection against diabetes-induced cardiac dysfunction, shown by increased absolute value of left ventricular systolic pressure (LVSP) and maximum rates of pressure development (±dp/dt max ), and enhanced amplitude of I Ca2+-L (P < 0.05). Histological staining indicated a significant inhibition of diabetes-caused pathological changes and up-regulation of CTGF expression (P < 0.05). The results suggest that TASAES prevents diabetes-induced cardiac dysfunction and pathological damage through up-regulating I Ca2+-L in cardiac cells and decreasing CTGF expression.

UR - http://www.scopus.com/inward/record.url?scp=70249103802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249103802&partnerID=8YFLogxK

U2 - 10.3858/emm.2009.41.8.059

DO - 10.3858/emm.2009.41.8.059

M3 - Article

VL - 41

SP - 538

EP - 547

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 8

ER -